Go Oshima
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Liver Disease and Transplantation
-
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 5
- Liver physiology and pathology 4
- Oncology 14
- Pancreatic and Hepatic Oncology Research 11
- Co-authors
- Yuko Kitagawa (31 shared papers)Osamu Itano (19 shared papers)Yuta Abe (24 shared papers)Minoru Kitago (24 shared papers)Hiroshi Yagi (12 shared papers)Masahiro Shinoda (6 shared papers)Taizo Hibi (10 shared papers)Shutaro Hori (13 shared papers)
- Journals
- World Journal of Surgical Oncology (3 papers)World Journal of Surgery (3 papers)Surgical Laparoscopy Endoscopy & Percutaneous Techniques (3 papers)Surgery (2 papers)BMC Cancer (2 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Go Oshima
48 papers receiving 517 citations
Peers
Comparison fields: 5 of 51
- Hepatology 85
- Oncology 149
- Surgery 192
- Clinical Biochemistry 11
- Emergency Medicine 8
Countries citing papers authored by Go Oshima
This map shows the geographic impact of Go Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Oshima more than expected).
Fields of papers citing papers by Go Oshima
This network shows the impact of papers produced by Go Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Oshima. The network helps show where Go Oshima may publish in the future.
Co-authors
The 25 scholars most cited alongside Go Oshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 71 | |
| 2 | 2011 | 60 | |
| 3 | 2020 | 34 | |
| 4 | 2020 | 30 | |
| 5 | 2011 | 25 | |
| 6 | 2020 | 24 | |
| 7 | 2012 | 23 | |
| 8 | 2019 | 19 | |
| 9 | 2018 | 18 | |
| 10 | 2014 | 17 | |
| 11 | 2019 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2009 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2018 | 8 | |
| 20 | 2021 | 8 |
About Go Oshima
Go Oshima is a scholar working on Hepatology, Oncology, Surgery, Clinical Biochemistry and Epidemiology, having authored 48 papers that have together received 524 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Liver Disease and Transplantation (5 papers), Organ Transplantation Techniques and Outcomes (4 papers), Liver physiology and pathology (4 papers), Advanced Glycation End Products research (3 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (85 citations), Oncology (149 citations), Surgery (192 citations), Clinical Biochemistry (11 citations) and Emergency Medicine (8 citations). Go Oshima has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Yuko Kitagawa, Osamu Itano, Yuta Abe, Minoru Kitago, Hiroshi Yagi, Masahiro Shinoda, Taizo Hibi, Shutaro Hori, Yohei Masugi and Naruhiko Ikoma. Their work appears in journals such as World Journal of Surgical Oncology, World Journal of Surgery, Surgical Laparoscopy Endoscopy & Percutaneous Techniques, Surgery and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.